📰 Abt News
Page 10 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
April 30, 2024
Choreo LLC raised its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 13.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 26,181 shares of the healthcare product maker’s stock after buying an additional 3,088 shares during the period. Choreo […]
April 30, 2024
Cary Street Partners Investment Advisory LLC cut its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 69.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 15,360 shares of the healthcare product maker’s stock after selling 35,555 shares during the quarter. […]
April 30, 2024
Choreo LLC lifted its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 13.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 26,181 shares of the healthcare product maker’s stock after buying an additional 3,088 shares during the period. Choreo LLC’s […]
April 30, 2024
Norden Group LLC lowered its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 13.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 20,424 shares of the healthcare product maker’s stock after selling 3,053 shares during the quarter. Abbott Laboratories makes […]
April 29, 2024
Blue Chip Partners LLC decreased its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 4.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 145,424 shares of the healthcare product maker’s stock after selling 6,636 shares during the quarter. Abbott […]
April 29, 2024
Argyle Capital Management Inc. decreased its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 32.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,615 shares of the healthcare product maker’s stock after selling 3,150 shares during the period. Argyle Capital […]
April 29, 2024
Adell Harriman & Carpenter Inc. cut its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 3.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 18,650 shares of the healthcare product maker’s stock after selling 702 shares during the quarter. Adell […]
April 28, 2024
Cornerstone Capital Inc. lowered its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 4.4% during the 4th quarter, Holdings Channel reports. The institutional investor owned 241,640 shares of the healthcare product maker’s stock after selling 11,176 shares during the quarter. Abbott Laboratories comprises about 2.9% of Cornerstone Capital Inc.’s holdings, making the stock its […]
April 28, 2024
Sector Gamma AS acquired a new stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 39,876 shares of the healthcare product maker’s stock, valued at approximately $4,389,000. Abbott Laboratories makes up 1.1% of Sector […]
April 28, 2024
IMA Wealth Inc. trimmed its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 10.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,152 shares of the healthcare product maker’s stock after selling 250 shares during the […]